Durvalumab (D) plus platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

---

Copy For Citation

Reinmuth N., Goldman J. W., Chen Y., Hotta K., Statsenko G., Hochmair M. J., ...More

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 9 - 13 September 2022, vol.33

• Publication Type: Conference Paper / Summary Text
• Volume: 33
• Doi Number: 10.1016/j.annonc.2022.07.1625
• Country: ELECTR NETWORK
• Istanbul University Affiliated: No